Andras Bilkei-Gorzo Selected Research

Memory Disorders (Memory Loss)

7/2011	Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging.
2/2006	Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andras Bilkei-Gorzo Research Topics

Disease

3	Hyperalgesia 07/2018 - 01/2004
3	Pain (Aches) 07/2018 - 11/2004
2	Body Weight (Weight, Body) 01/2020 - 01/2011
2	Memory Disorders (Memory Loss) 07/2011 - 02/2006
1	Overweight 01/2020
1	Obesity 01/2020
1	Neuralgia (Stump Neuralgia) 07/2018
1	Alzheimer Disease (Alzheimer's Disease) 05/2014
1	Mental Disorders (Mental Disorder) 01/2013
1	Mood Disorders (Mood Disorder) 01/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2012
1	Mania (Manias) 09/2012
1	Hypersensitivity (Allergy) 09/2012
1	Wounds and Injuries (Trauma) 07/2012
1	Cognitive Dysfunction 07/2011
1	Neuroinflammatory Diseases 07/2011
1	Virus Diseases (Viral Diseases) 01/2011
1	Chronic Hepatitis C 01/2011
1	Depressive Disorder (Melancholia) 01/2011
1	Neoplasms (Cancer) 01/2011
1	Anhedonia 01/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2010
1	Respiratory Insufficiency (Respiratory Failure) 01/2010
1	Hypoxia (Hypoxemia) 01/2010
1	Catalepsy 10/2008
1	Hyperthermia 05/2008
1	Edema (Dropsy) 03/2008
1	Inflammation (Inflammations) 03/2008
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2008
1	Shock 01/2008
1	Tobacco Use Disorder (Nicotine Dependence) 02/2005
1	Alcoholism (Alcohol Abuse) 03/2003
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 03/2003
1	Anxiety Disorders (Anxiety Disorder) 11/2002
1	Pathologic Processes 11/2002

Drug/Important Bio-Agent (IBA)

3	CannabinoidsIBA 07/2018 - 03/2003
2	Dynorphins (Dynorphin)IBA 01/2020 - 05/2008
2	EndocannabinoidsIBA 07/2018 - 07/2011
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 07/2011 - 03/2003
2	CytokinesIBA 07/2011 - 01/2011
2	TachykininsIBA 01/2010 - 11/2002
2	Purinergic P1 Receptor AntagonistsIBA 03/2008 - 01/2004
2	Nicotine FDA Link 01/2008 - 02/2005
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Neutralizing AntibodiesIBA 07/2018
1	Leptin ReceptorsIBA 07/2018
1	CB2 Cannabinoid ReceptorIBA 07/2018
1	LeptinIBA 07/2018
1	Proteins (Proteins, Gene)FDA Link 05/2014
1	Amyloid (Amyloid Fibrils)IBA 05/2014
1	Serine (L-Serine)FDA Link 01/2013
1	Amphetamine (Amfetamine)FDA LinkGeneric 09/2012
1	NeurocanIBA 09/2012
1	SaccharinIBA 09/2012
1	ElementsIBA 07/2012
1	Interleukin-6 (Interleukin 6)IBA 07/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2011
1	Sucrose (Saccharose)IBA 01/2011
1	K Cl- CotransportersIBA 10/2010
1	Potassium Chloride FDA LinkGeneric 10/2010
1	Morphine (MS Contin)FDA LinkGeneric 01/2010
1	Opioid Analgesics (Opioids)IBA 01/2010
1	Ondansetron (Zofran)FDA LinkGeneric 10/2008
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2008
1	anandamide (arachidonylethanolamide)IBA 10/2008
1	1-propyl-8-(4-sulfophenyl)xanthineIBA 03/2008
1	Analgesics (Analgesic Drugs)IBA 03/2008
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2008
1	CarrageenanIBA 03/2008
1	1- butyl- 8- (3- noradamantyl)- 3- (3- hydroxypropyl)xanthineIBA 03/2008
1	Formaldehyde (Formol)FDA Link 03/2008
1	Glucose (Dextrose)FDA LinkGeneric 02/2006
1	AcetylcholinesteraseIBA 02/2006
1	Opioid Peptides (Opioid Peptide)IBA 02/2005
1	preproenkephalinIBA 02/2005
1	Pharmaceutical PreparationsIBA 11/2004
1	Ethanol (Ethyl Alcohol)IBA 03/2003
1	NeuropeptidesIBA 11/2002
1	Substance PIBA 11/2002

Therapy/Procedure

1	Analgesia 10/2008